Investigating the effect of vitamin D on surgical site infection

Investigating the effect of preoperative vitamin D consumption on surgical site infection

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240419061523N1

Enrollment

220

Registered

2024-05-09

Start date

2024-05-20

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infections in gynecological surgeries. Infection following a procedure

Interventions

Intervention 1: Intervention group: In addition to routine care before and after surgery, the intervention group will receive 2 tablets of 50,000 units of vitamin D (Dana Pharmaceutical Company) (one

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Candidate patients for elective gynecological surgeries (hysterectomy, oophorectomy and ovarian cyst, cancer) Women over 18 years old and under 80 years old Willingness of patients to participate in research Not receiving corticosteroids or immunosuppressive drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The incidence of surgical site infection in gynecological surgeries. Timepoint: Examining the rate of infection on days 1, 3, 7 and 30 after surgery. Method of measurement: Based on the symptoms of infection (swelling, redness, erythema, pain, purulent secretions and fever), which is confirmed by the relevant surgeon.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Norouzi

Kashan University of Medical Sciences

norouzi-na@kaums.ac.ir+98 31 5510 3142

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026